D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment

Thrombosis Research

Volumn 146, Issue , 2016, Pages 119-125

  Kearon, C ^a   Parpia, S ^a   Spencer, F A ^a   Baglin, T ^b   Stevens, S M ^c   Bauer, K A ^d   Lentz, S R ^e   Kessler, C M ^f   Douketis, J D ^a   Moll, S ^g   Kaatz, S ^h   Schulman, S ^a   Connors, J M ^d   Ginsberg, J S ^a   Spadafora, L ^a   Liaw, P C ^a   Weitz, J I ^a   Julian, J A ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h HURLEY MEDICAL CENTER   (United States)

Author keywords

Cohort study; D dimer; Forecasting; Prognosis; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT WITHDRAWAL; VENOUS THROMBOEMBOLISM; COHORT ANALYSIS; METABOLISM; PROGNOSIS; RISK FACTOR;

ANTICOAGULANTS; COHORT STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84977645871     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2016.06.023     Document Type: Article

References (14)

1. [1] Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cushman, M., Eichinger, S., Palareti, G., Poli, D., Tait, R.C., Iorio, A., Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann. Intern. Med. 153:8 (2010), 523–531.
2. [2] Palareti, G., Cosmi, B., Legnani, C., Tosetto, A., Brusi, C., Iorio, A., Pengo, V., Ghirarduzzi, A., Pattacini, C., Testa, S., Lensing, A.W., Tripodi, A., D-dimer testing to determine the duration of anticoagulation therapy. N. Engl. J. Med. 355:17 (2006), 1780–1789.
3. [3] Kearon, C., Akl, E.A., Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 123:12 (2014), 1794–1801.
4. [4] Kearon, C., Spencer, F.A., O'Keeffe, D., Parpia, S., Schulman, S., Baglin, T., Stevens, S.M., Kaatz, S., Bauer, K.A., Douketis, J.D., Lentz, S.R., Kessler, C.M., Moll, S., Connors, J.M., Ginsberg, J.S., Spadafora, L., Julian, J.A., D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. Ann. Intern. Med. 162:1 (2015), 27–34.
5. [5] Palareti, G., Cosmi, B., Legnani, C., Antonucci, E., De, M.V., Ghirarduzzi, A., Poli, D., Testa, S., Tosetto, A., Pengo, V., Prandoni, P., D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124:2 (2014), 196–203.
6. [6] Palareti, G., D-dimer testing in patients with a first unprovoked venous thromboembolism. Ann. Intern. Med. 162:9 (2015), 670–671.
7. [7] Cosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A., Palareti, G., Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension. J. Thromb. Haemost. 8:9 (2010), 1933–1942.
8. [8] Cosmi, B., Legnani, C., Tosetto, A., Pengo, V., Ghirarduzzi, A., Testa, S., Prisco, D., Poli, D., Tripodi, A., Marongiu, F., Palareti, G., Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood 115:3 (2010), 481–488.
9. [9] Neale, D., Tovey, C., Vali, A., Davies, S., Myers, K., Obiako, M., Ramkumar, V., Hafiz, A., Evaluation of the simplify D-dimer assay as a screening test for the diagnosis of deep vein thrombosis in an emergency department. Emerg. Med. J. 21:6 (2004), 663–666.
10. [10] Cini, M., Legnani, C., Cavallaroni, K., Bettini, F., Palareti, G., A new rapid bedside assay for D-dimer measurement (simplify D-dimer) in the diagnostic work-up for deep vein thrombosis. J. Thromb. Haemost. 1:12 (2003), 2681–2683.
11. [11] Kearon, C., Stevens, S.M., Julian, J.A., D-dimer testing in patients with a first unprovoked venous thromboembolism. Ann. Intern. Med., 162(9), 2015, 671.
12. [12] Verhovsek, M., Douketis, J.D., Yi, Q., Shrivastava, S., Tait, R.C., Baglin, T., Poli, D., Lim, W., Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann. Intern. Med. 149:7 (2008), 481–490 (W94).
13. [13] Douketis, J., Tosetto, A., Marcucci, M., Baglin, T., Cosmi, B., Cushman, M., Kyrle, P., Poli, D., Tait, R.C., Iorio, A., Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. Br. Med. J., 342, 2011, d813.
14. [14] Rodger, M.A., Kahn, S.R., Wells, P.S., Anderson, D.A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., Vickars, L., Ramsay, T., Betancourt, M.T., Kovacs, M.J., Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179:5 (2008), 417–426.